279 related articles for article (PubMed ID: 34690279)
21. COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis.
Batu ED; Sener S; Ozen S
Semin Arthritis Rheum; 2022 Aug; 55():152047. PubMed ID: 35709649
[TBL] [Abstract][Full Text] [Related]
22. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
Naderi-Azad S; Vender R
J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous manifestations of COVID-19.
Wang CJ; Worswick S
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
[TBL] [Abstract][Full Text] [Related]
24. Microscopic polyarteritis. Report of a case with cutaneous involvement and antimyeloperoxidase antibodies.
Homas PB; David-Bajar KM; Fitzpatrick JE; West SG; Tribelhorn DR
Arch Dermatol; 1992 Sep; 128(9):1223-8. PubMed ID: 1325755
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.
Marzano AV; Raimondo MG; Berti E; Meroni PL; Ingegnoli F
Clin Rev Allergy Immunol; 2017 Dec; 53(3):428-438. PubMed ID: 28578472
[TBL] [Abstract][Full Text] [Related]
26. Clinical approach to cutaneous vasculitis.
Chen KR; Carlson JA
Am J Clin Dermatol; 2008; 9(2):71-92. PubMed ID: 18284262
[TBL] [Abstract][Full Text] [Related]
27. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
28. Approach to cutaneous vasculitides with special emphasis on small vessel vasculitis: histopathology and direct immunofluorescence.
Demirkesen C
Curr Opin Rheumatol; 2017 Jan; 29(1):39-44. PubMed ID: 27787337
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients.
Chen KR; Kawahara Y; Miyakawa S; Nishikawa T
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):689-96. PubMed ID: 9146529
[TBL] [Abstract][Full Text] [Related]
30. Systemic vasculitis--is it time to reclassify?
Watts RA; Suppiah R; Merkel PA; Luqmani R
Rheumatology (Oxford); 2011 Apr; 50(4):643-5. PubMed ID: 20647295
[No Abstract] [Full Text] [Related]
31. Cutaneous Vasculitis in Cogan's Syndrome: A Report of Two Cases Associated with Chlamydia Infection.
Kawasaki Y; Uehara T; Kawana S
J Nippon Med Sch; 2018; 85(3):172-177. PubMed ID: 30135344
[TBL] [Abstract][Full Text] [Related]
32. Recurrent erythema nodosum: a red flag sign of hidden systemic vasculitis.
Gupta M; Singh K; Lehl SS; Bhalla M
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576669
[TBL] [Abstract][Full Text] [Related]
33. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
34. Beyond Giant Cell Arteritis and Takayasu's Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers.
Berti A; Moura MC; Sechi E; Squizzato F; Costanzo G; Chen JJ; Warrington KJ
Curr Rheumatol Rep; 2020 Nov; 22(12):88. PubMed ID: 33159612
[TBL] [Abstract][Full Text] [Related]
35. Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.
Delaval L; Samson M; Schein F; Agard C; Tréfond L; Deroux A; Dupuy H; Garrouste C; Godmer P; Landron C; Maurier F; le Guenno G; Rieu V; Desblache J; Durel CA; Jousselin-Mahr L; Kassem H; Pugnet G; Queyrel V; Swiader L; Blockmans D; Sacré K; Lazaro E; Mouthon L; Aumaître O; Cathébras P; Guillevin L; Terrier B;
Arthritis Rheumatol; 2021 Feb; 73(2):286-294. PubMed ID: 32951354
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature.
Sørensen SF; Slot O; Tvede N; Petersen J
Ann Rheum Dis; 2000 Jun; 59(6):478-82. PubMed ID: 10834866
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients.
Magro CM; Crowson AN
J Cutan Pathol; 2003 Jan; 30(1):1-10. PubMed ID: 12534797
[TBL] [Abstract][Full Text] [Related]
38. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
Sunderkötter C; Michl C
Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells.
Giryes S; Bragazzi NL; Bridgewood C; De Marco G; McGonagle D
Semin Immunopathol; 2022 May; 44(3):375-390. PubMed ID: 35412072
[TBL] [Abstract][Full Text] [Related]
40. An update on the nomenclature for cutaneous vasculitis.
Caproni M; Verdelli A
Curr Opin Rheumatol; 2019 Jan; 31(1):46-52. PubMed ID: 30394939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
